Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,513	Closed	-$844K	–	3771
2025 Q4	$844K	Buy	1,513 +805	+114%	+$411K	﹤0.01%	2069
2025 Q3	$309K	Buy	708 +7	+1%	+$2.61K	﹤0.01%	2769
2025 Q2	$210K	Buy	+701	New	+$209K	﹤0.01%	2955
2025 Q1	–	Sell	-680	Closed	-$210K	–	3081
2024 Q4	$210K	Buy	+680	New	+$191K	﹤0.01%	2662
2024 Q2	–	Sell	-973	Closed	-$260K	–	2666
2024 Q1	$260K	Buy	+973	New	+$229K	﹤0.01%	2009

Other funds holding MDGL

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return